You are here: Industry Insights > Oncology

News List

FDA takes first action under new international collaboration with Australia and Canada worldpharmanews
September 18, 2019
The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE).
Pneumagen Appoints Scientific Advisory Board americanpharmaceuticalreview
September 03, 2019
Pneumagen announced appointments to its Scientific Advisory Board (SAB), adding expertise in the areas of respiratory disease, immunology and oncology.
US appeals court overturns patent case for Jevtana europeanpharmaceuticalreview
August 20, 2019
Sanofi has won the latest appeal for the patent of its top oncology product, Jevtana (cabazitaxel).
Daiichi Sankyo wades deeper into oncology with FDA go-ahead in rare joint cancer fiercepharma
August 13, 2019
In a win for Daiichi Sankyo’s big pivot to oncology, the Japanese drugmaker has snatched its first U.S. cancer nod since 2011—and it’s also the first FDA-approved drug for a rare joint tumor.
Syapse, Pfizer in Oncology Precision Medicine Pact contractpharma
July 25, 2019
o focus on outcomes research using Real-World Evidence.
Ziopharm Oncology Names Chief Financial Officer drugs
July 25, 2019
Shukla joins the company from Vertex Pharmaceuticals; Served as VP and global Head of Corporate Finance.
CytomX Therapeutics Announces Second Target Selection with AbbVie contractpharma
July 10, 2019
Multi-Program oncology collaboration triggers $10 million milestone payment to CytomX.
Ziopharm Oncology Achieves Positive Results for Glioblastoma Treatment contractpharma
June 19, 2019
Controlled IL-12 platform appears to have activity as a monotherapy and is now being studied in an expanded group of patients.
Jeff Settleman, Ph.D., joins Pfizer to lead Oncology Research & Development worldpharmanews
June 10, 2019
Jeff Settleman, Ph.D., joins Pfizer to lead Oncology Research & Development.
Amgen joins with community oncology networks for new research collaboration worldpharmanews
May 29, 2019
Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiative to enhance access by community centers to innovative oncology clinical research.